Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cCeLL In Vivo for Intraoperative Brain Tumor Diagnosis
NCT06867978Phase 1Not yet recruiting
- Sponsor
- VPIX Medical
- Start
- Jun 2025
- Primary completion
- Jun 2026
01
Overview
Phase 1, single-blind, single-arm trial in brain tumor, sponsored by VPIX Medical. Primary endpoint: Non-Inferiority of Diagnostic Accuracy (Percentage of Correct Normal/Tumor Classifications) of cCeLL Compared to Frozen Biopsy. Planned start Jun 2025; status: not yet recruiting.
02
Conditions
brain tumor
Beyond the preview
Go deeper on NCT06867978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06867978.